多囊卵巢综合征女性的克罗米芬阶梯式方案
该回顾性研究纳入2012年7月至2014年7月在某大学附属不孕门诊就诊、对克罗米芬初始剂量50 mg抵抗的多囊卵巢综合征(PCOS)不孕女性,比较传统方案与阶梯式方案的排卵时间、排卵率及不良反应。结果显示阶梯式方案排卵时间更短、150 mg与200 mg剂量下排卵率更高, mild 不良反应更多,严重不良反应无差异。
要点
- 阶梯式方案排卵时间23.1±0.9天,短于传统方案的47.5±6.3天。
- 150 mg时排卵率阶梯式组16例(37%)高于传统组8例(12%),P=.004。
- 200 mg时排卵率阶梯式组9例(21%)高于传统组3例(5%),P=.01。
核心结论
- 对PCOS女性,与传统方案相比,克罗米芬阶梯式方案与排卵时间缩短及较高剂量下排卵率增加相关。
研究设计与样本
- 回顾性研究,纳入2012年7月至2014年7月某大学附属不孕门诊因不孕就诊、诊断为PCOS且对克罗米芬初始剂量50 mg抵抗的患者,共109例,其中传统方案组66例(60.6%)、阶梯式方案组43例(39.4%)。
- 研究把握度为80%,用于检测排卵率20%的差异。
主要发现
- 排卵时间阶梯式方案组23.1±0.9天,短于传统方案组47.5±6.3天。
- 150 mg剂量下排卵率阶梯式组16例(37%),高于传统组8例(12%),P=.004。
- 200 mg剂量下排卵率阶梯式组9例(21%),高于传统组3例(5%),P=.01。
- 一旦实现排卵,两组妊娠率相似:传统组12例(18.1%)vs 阶梯式组7例(16.3%),P=.08。
- 轻度不良反应(血管舒缩性潮红、头痛、胃肠道不适、乳房胀痛、情绪改变)阶梯式组18例(41%),多于传统组8例(12%);严重不良反应(头痛、视觉障碍)两组无差异。
临床怎么用
- 作者认为,对PCOS女性,与传统方案相比,克罗米芬阶梯式方案与排卵时间缩短及较高剂量下排卵率增加相关。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare time to ovulation, ovulation rates, and side effect profile of traditional and the stair-step protocol for ovulation induction using clomiphene citrate in women with polycystic ovary syndrome (PCOS). METHODS: We performed a retrospective study of women seeking care for infertility with a diagnosis of PCOS at a university-based infertility clinic from July 2012 to July 2014. We included patients who were resistant to the initial starting dose of 50 mg clomiphene. The primary outcome was time to ovulation. Secondary outcomes included ovulation rates, clinical pregnancy rates, and mild and moderate-to-severe side effects based on dose. For the traditional protocol, higher doses of clomiphene were used each subsequent month if no ovulation occurred. For the stair-step protocol, higher doses of clomiphene were given 7 days after the last dose if no dominant follicles were seen on ultrasonography. Our study had 80% power to detect a 20% difference in ovulation. RESULTS: One hundred nine patients were included in the analysis with 66 (60.6%) in the traditional and 43 (39.4%) in the stair-step protocol. Age and body mass index were similar between groups. The time to ovulation was decreased in the stair-step protocol group compared with the traditional protocol group (23.1±0.9 days vs 47.5±6.3 days). Ovulation rates were increased in the stair-step group compared with the traditional group at 150 mg (16 [37%] vs 8 [12%], P=.004) and at 200 mg (9 [21%] vs 3 [5%], P=.01). Pregnancy rates were similar between groups once ovulation was achieved (12 [18.1%] vs 7 [16.3%], P=.08). The stair-step protocol had an increased incidence of mild side effects (vasomotor flushes, headaches, gastrointestinal disturbance, mastalgia, changes in mood; 18 [41%] vs 8 [12%]), but there was no difference in the incidence of severe side effects (headaches, visual disturbances). CONCLUSION: For women with PCOS, the stair-step clomiphene protocol is associated with decreased time to ovulation and increased ovulation rates at higher doses when compared with the traditional protocol.
引用
- Jones T, Ho JR, Gualtieri M, et al. Clomiphene Stair-Step Protocol for Women With Polycystic Ovary Syndrome. Obstet Gynecol. 2018. PMID: 29215516. doi:10.1097/AOG.0000000000002418
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。